USANA Health Sciences Inc... (USNA)

NYSE: USNA · Real-Time Price · USD

27.81

-0.28 (-1.00%)

At close: May 01, 2025, 12:12 PM

-1.00% (1D)

Bid	27.8
Market Cap	524.5M
Revenue (ttm)	854.5M
Net Income (ttm)	42.06M
EPS (ttm)	1.82
PE Ratio (ttm)	15.28
Forward PE	9.13
Analyst	Hold

Ask	27.95
Volume	59,127
Avg. Volume (20D)	247,678.7
Open	27.98
Previous Close	28.09
Day's Range	27.58 - 28.29
52-Week Range	23.10 - 49.78
Beta	1.00

About USNA

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; a...

[Read more]

Industry Packaged Foods

Sector Consumer Defensive

IPO Date Apr 4, 1994

Employees 1,700

Stock Exchange NYSE

Ticker Symbol USNA

Website https://www.usana.com

Full Company Profile

Analyst Forecast

According to 1 analyst ratings, the average rating for USNA stock is "Hold." The 12-month stock price forecast is $36, which is an increase of 29.45% from the latest price.

Stock Forecasts

Earnings Surprise

USANA Health Sciences has released their quartely earnings on Apr 22, 2025:

Revenue of $249.54M exceeds estimates by $6.5M, with 9.54% YoY growth.

EPS of 0.73 exceeds estimates by 0.03, with -15.12% YoY decline.

Why Price Moved

1 week ago

+4.91%

Usana Health Sciences shares are trading higher af... Unlock content with Pro Subscription

3 weeks ago

+4.42%

Shares of consumer staple companies are trading higher following President Trump's decision to implement a 90-day pause on reciprocal tariffs for all countries except China.

News

1 week ago · seekingalpha.com

USANA Health Sciences, Inc. (USNA) Q1 2025 Earnings Call Transcript

USANA Health Sciences, Inc. (NYSE:USNA ) Q1 2025 Earnings Conference Call April 23, 2025 11:00 AM ET Company Participants Andrew Masuda - Director, Investor Relations Jim Brown - President and Chief E...

1 week ago · zacks.com

USANA Health Sciences (USNA) Q1 Earnings and Revenues Surpass Estimates

USANA Health Sciences (USNA) came out with quarterly earnings of $0.73 per share, beating the Zacks Consensus Estimate of $0.70 per share. This compares to earnings of $0.86 per share a year ago.

1 week ago · businesswire.com

USANA Health Sciences Reports First Quarter 2025 Results and Reiterates Full-Year Outlook

SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for its fiscal first quarter ended March 29, 2025. Key Financial Results First Quarter 2025 ...

2 months ago · seekingalpha.com

USANA Health Sciences, Inc. (USNA) Q4 2024 Earnings Conference Call Transcript

USANA Health Sciences, Inc. (NYSE:USNA ) Q4 2024 Earnings Conference Call February 26, 2025 11:00 AM ET Company Participants Andrew Masuda - IR Jim Brown - President and CEO Brent Neidig - Chief Comme...

2 months ago · zacks.com

USANA Health Sciences (USNA) Surpasses Q4 Earnings and Revenue Estimates

USANA Health Sciences (USNA) came out with quarterly earnings of $0.64 per share, beating the Zacks Consensus Estimate of $0.49 per share. This compares to earnings of $0.87 per share a year ago.

2 months ago · zacks.com

Should Value Investors Buy USANA Health Sciences (USNA) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest...

2 months ago · zacks.com

5 Low Price-to-Book Stocks Worthy of Value Investors' Attention

The P/B ratio helps to identify low-priced stocks with high growth prospects. GM, KT, GBX, USNA and ENS are some such stocks.

2 months ago · zacks.com

USNA or STVN: Which Is the Better Value Stock Right Now?

Investors interested in Medical - Drugs stocks are likely familiar with USANA Health Sciences (USNA) and Stevanato Group (STVN). But which of these two stocks presents investors with the better value ...

2 months ago · zacks.com

5 Promising Price-to-Book Value Stocks to Buy in February

The P/B ratio helps to identify low-priced stocks with high growth prospects. GM, USNA, GBX, KT and ENS are some such stocks.